A study released Friday by Oregon State University researchers say compounds found in Cannabis sativa showed the ability to prevent the coronavirus from entering human cells. “Van Breemen and collaborators, including scientists at Oregon Health & Science University, found that a pair of cannabinoid acids bind to the SARS-CoV-2 spike protein, blocking a critical step in the process the virus uses to infect people,” says a news release from Oregon State. In fact, those acid substances in cannabis are the same ones used in COVID-19 vaccines and antibody therapy. They have a good safety profile in humans, not being psychoactive ingredients in marijuana. „Using compounds that block virus-receptor interaction has been helpful for patients with other viral infections, he says, including HIV-1 and hepatitis,” the researchers also said.
The problem at this time is generated by outdates cannabis regulations which are blocking research and benefits of research. The findings could offer an additional pathway to slowing the spread of COVID-19 and subsequent variants and could play a significant role in global response to the pandemic. “We weren’t allowed to purify [precursor THC-A] and even test it alone, because it can be converted to THC,” van Breemen told media. It’s a long way to could use such research to help humans. “Research on the health effects of cannabis and cannabinoids has been limited in the United States, leaving patients, health care professionals, and policy makers without the evidence they need to make sound decisions,” the authors wrote.